Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...

A New Pacemaker Algorithm for the Treatment of Atrial Fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT) Electrophysiologic Characteristics of the Spontaneous Onset and ...

Saint Francis treated its first patient with pulsed-field ablation, which delivers pulsed electric fields to tissue to treat ...

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to ...

Researchers have found that Factor XI inhibitors, such as abelacimab, reduce bleeding risks in atrial fibrillation patients more effectively than standard anticoagulants.

less invasive treatment option. The Medtronic PulseSelect™ Pulsed Field Ablation System uses pulsed electric fields to target and eliminate the muscle cells that cause AFib. This innovative ...

The Ordensklinikum Linz Elisabethinen is one of the first centers worldwide and the first center in Austria to use a new method for the treatment of ...

Cardiovascular management strategies are essential to individuals with chronic lymphocytic leukemia (CLL) or multiple myeloma (MM) undergoing active treatment, due to the high rate of atrial ...

At McLeod Regional Medical Center, McLeod Electrophysiologists Dr. Prabal Guha and Dr. Cyrus Kocherla are performing safe and successful ablations in patients using the new FDA-approved pulsed field ...

29,427 people played the daily Crossword recently. Can you solve it faster than others?29,427 people played the daily Crossword recently. Can you solve it faster than others?